Performance of RPA-LF for Cutaneous Leishmaniasis
Launched by CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS · Aug 3, 2020
Trial Information
Current as of July 24, 2025
Completed
Keywords
ClinConnect Summary
CL is public health in the Americas with an average of 55,000 cases per year between 2001 - 2018 in 17 countries, which mainly occur in rural areas with an average of 55,000 cases per year between 2001 - 2018 in 17 countries. Diagnostic confirmation is required to start treatment, however current diagnostic methods have several limitations, and sometimes it is necessary to perform confirmatory tests that are not available in endemic areas.
Several molecular diagnostic tests have been developed for the diagnosis of CL, however, the technical requirements and costs of sample processing by co...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Men or women with 2 years of age and over of any ethnic group
- • Ulcerated skin lesions compatible with cutaneous leishmaniasis with two or more weeks of duration
- • Approval of informed consent
- Exclusion Criteria:
- • Mucosal leishmaniasis
- • Clinical presentations of cutaneous leishmaniasis different of ulcerated lesions
About Centro Internacional De Entrenamiento E Investigaciones Médicas
Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM) is a leading clinical research organization dedicated to advancing medical knowledge through rigorous scientific investigation and training. Located in Colombia, CIDEIM specializes in the design and execution of clinical trials across various therapeutic areas, with a strong emphasis on infectious diseases and public health. The center is committed to fostering innovation and collaboration among local and international stakeholders, ensuring high ethical standards and compliance with regulatory guidelines. Through its comprehensive training programs and robust research capabilities, CIDEIM aims to contribute significantly to global health advancements and the development of new therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cali, Valle, Colombia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials